Trump’s Cannabis Rescheduling Push Could Create a Massive Opportunity – And This Company Is Perfectly Positioned
InterCure’s Newly Announced Strategic Acquisition of ISHI Comes at Historic Inflection Point as Trump Administration Explores Cannabis Rescheduling
